| scholarly article | Q13442814 |
| P2093 | author name string | Han Chong Toh | |
| Kian Fong Foo | |||
| Richard Quek | |||
| Wen Hsin Koo | |||
| Wan Teck Lim | |||
| Afidah A-Manaf | |||
| P2860 | cites work | Phase I trial of 5-day continuous venous infusion of oxaliplatin at circadian rhythm-modulated rate compared with constant rate | Q41231593 |
| Incidence of cardiotoxicity with the oral fluoropyrimidine capecitabine is typical of that reported with 5-fluorouracil | Q43983646 | ||
| Oxaliplatin and capecitabine in patients with metastatic adenocarcinoma of the esophagus, gastroesophageal junction and gastric cardia: a phase II study from the North Central Cancer Treatment Group | Q46816804 | ||
| Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer. | Q53604465 | ||
| Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer. | Q53610419 | ||
| Phase II study of oxaliplatin, fluorouracil, and folinic acid in locally advanced or metastatic gastric cancer patients | Q33345474 | ||
| Phase II trial of biweekly infusional fluorouracil, folinic acid, and oxaliplatin in patients with advanced gastric cancer | Q33359580 | ||
| XELOX (capecitabine plus oxaliplatin): active first-line therapy for patients with metastatic colorectal cancer | Q33978749 | ||
| A systematic overview of chemotherapy effects in gastric cancer | Q34301229 | ||
| P433 | issue | 7 | |
| P921 | main subject | capecitabine | Q420207 |
| oxaliplatin | Q422327 | ||
| P304 | page(s) | 1032-1034 | |
| P577 | publication date | 2007-01-01 | |
| P1433 | published in | Acta Oncologica | Q326164 |
| P1476 | title | Capecitabine and oxaliplatin (XELOX) is safe and effective in patients with advanced gastric cancer | |
| P478 | volume | 46 |
| Q55514438 | Cost-effectiveness analysis of capecitabine monotherapy versus capecitabine plus oxaliplatin in elderly patients with advanced gastric cancer. |
| Q87269121 | Efficacy and safety of capecitabine as maintenance treatment after first-line chemotherapy using oxaliplatin and capecitabine in advanced gastric adenocarcinoma patients: a prospective observation |
| Q37477979 | Evaluation of Outcome and Tolerability of Combination Chemotherapy with Capecitabine and Oxaliplatin as First Line Therapy in Advanced Gastric Cancer |
| Q33426501 | S-1 plus cisplatin versus fluorouracil plus cisplatin in advanced gastric or gastro-esophageal junction adenocarcinoma patients: a pilot study |
Search more.